Who Soumya Swaminathan
-
{
- All
- News
- Videos
-
"Outbreak Can Be Contained": Dr Soumya Swaminathan On Hantavirus Crisis
Dr. Swaminathan emphasised Hantavirus' limited transmissibility despite human-to-human spread. She also speaks about the Andes strain, the only known hantavirus variant capable of person-to-person transmission.
-
AI Can Transform Healthcare In Areas Lacking Specialists: Ex-WHO Deputy Director-General Soumya Swaminathan
Former Deputy Director-General of the World Health Organisation, Soumya Swaminathan, on Friday said artificial intelligence can have a significant positive impact on healthcare, especially in regions where specialist doctors are scarce.
-
"Rich Nations Contribute More To WHO": Soumya Swaminathan on Trump's Funding Remarks
Former chief scientist of the World Health Organisation, Soumya Swaminathan on Saturday said the US opting out of WHO would not be good for anyone including that country.
-
Keeping Tab On Number Of HMPV Cases "Meaningless": Ex-WHO Chief Scientist
Former WHO chief scientist Soumya Swaminathan said the HMPV infection has been in circulation in India for several years. Seven cases have been registered in the country so far.
-
WHO Ex Chief Scientist Says HMPV Nothing To Panic About, Lists Precautions
Human Metapneumovirus (HMPV) is nothing to panic about, former chief scientist of the World Health Organisation Dr Soumya Swaminathan said.
-
"A Fitting Tribute": Ex WHO Chief Scientist On Bharat Ratna To Father
The family is very happy and delighted with the honour, said Dr Soumya Swaminathan, former chief scientist of WHO and the daughter of noted agricultural scientist MS Swaminathan who was honoured with the Bharat Ratna today.
-
"Need To Be Cautious, Not Panic": Ex WHO Chief Scientist On New Covid Variant
Amid the rising new JN.1 Covid-19 variant scare, former World Health Organisation (WHO) chief scientist Dr Soumya Swaminathan asserted that there is no need to panic currently as it is a variant of interest and not of concern.
-
WHO To Update List Of Pathogens That Can Cause Future Outbreaks, Will Include "Disease X"
The list of priority pathogens will help researchers identify where they need to invest energy and funds to develop tests, treatments and vaccines.
-
New Omicron Variant Is Immune Evasive, Says WHO Chief Scientist
With India reporting a highly infectious new COVID-19 variant, World Health Organization Chief Scientist Soumya Swaminathan on Friday said that there were over 300 sub-variants and XBB being a recombinant virus is a matter of concern.
-
Omicron Variant May Cause Another Covid Wave: WHO Chief Scientist
Chief scientist at the World Health Organization (WHO), Dr Soumya Swaminathan, on Thursday said some countries may see "another wave of infections" with the XBB subvariant of Omicron, a variant of COVID-19 virus.
-
WHO Chief Scientist Says Deaths Due To Indian Cough Syrup In Gambia "Serious Issue"
Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.
-
"Main Lesson From Pandemic Is...": WHO Chief Scientist To NDTV
Speaking to NDTV, when asked about the validity of vaccines as many got infected with Covid even after taking booster doses, she said the doses prevent severe disease.
-
Monkeypox Has Been A "Wake-Up Call", Says WHO Chief Scientist
The outbreak of Monkeypox has been a "wake-up call", Chief Scientist at the World Health Organisation, Soumya Swaminathan has said.
-
In WHO Chief Scientist's Reply To World Bank Adviser, A Covid Warning
Be prepared for fresh COVID-19 waves, WHO chief scientist Soumya Swaminathan has warned, amid the onset of new variants that are more transmissible, immune evasive and growing concerns about greater hospitalisations.
-
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
-
"Outbreak Can Be Contained": Dr Soumya Swaminathan On Hantavirus Crisis
Dr. Swaminathan emphasised Hantavirus' limited transmissibility despite human-to-human spread. She also speaks about the Andes strain, the only known hantavirus variant capable of person-to-person transmission.
-
AI Can Transform Healthcare In Areas Lacking Specialists: Ex-WHO Deputy Director-General Soumya Swaminathan
Former Deputy Director-General of the World Health Organisation, Soumya Swaminathan, on Friday said artificial intelligence can have a significant positive impact on healthcare, especially in regions where specialist doctors are scarce.
-
"Rich Nations Contribute More To WHO": Soumya Swaminathan on Trump's Funding Remarks
Former chief scientist of the World Health Organisation, Soumya Swaminathan on Saturday said the US opting out of WHO would not be good for anyone including that country.
-
Keeping Tab On Number Of HMPV Cases "Meaningless": Ex-WHO Chief Scientist
Former WHO chief scientist Soumya Swaminathan said the HMPV infection has been in circulation in India for several years. Seven cases have been registered in the country so far.
-
WHO Ex Chief Scientist Says HMPV Nothing To Panic About, Lists Precautions
Human Metapneumovirus (HMPV) is nothing to panic about, former chief scientist of the World Health Organisation Dr Soumya Swaminathan said.
-
"A Fitting Tribute": Ex WHO Chief Scientist On Bharat Ratna To Father
The family is very happy and delighted with the honour, said Dr Soumya Swaminathan, former chief scientist of WHO and the daughter of noted agricultural scientist MS Swaminathan who was honoured with the Bharat Ratna today.
-
"Need To Be Cautious, Not Panic": Ex WHO Chief Scientist On New Covid Variant
Amid the rising new JN.1 Covid-19 variant scare, former World Health Organisation (WHO) chief scientist Dr Soumya Swaminathan asserted that there is no need to panic currently as it is a variant of interest and not of concern.
-
WHO To Update List Of Pathogens That Can Cause Future Outbreaks, Will Include "Disease X"
The list of priority pathogens will help researchers identify where they need to invest energy and funds to develop tests, treatments and vaccines.
-
New Omicron Variant Is Immune Evasive, Says WHO Chief Scientist
With India reporting a highly infectious new COVID-19 variant, World Health Organization Chief Scientist Soumya Swaminathan on Friday said that there were over 300 sub-variants and XBB being a recombinant virus is a matter of concern.
-
Omicron Variant May Cause Another Covid Wave: WHO Chief Scientist
Chief scientist at the World Health Organization (WHO), Dr Soumya Swaminathan, on Thursday said some countries may see "another wave of infections" with the XBB subvariant of Omicron, a variant of COVID-19 virus.
-
WHO Chief Scientist Says Deaths Due To Indian Cough Syrup In Gambia "Serious Issue"
Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.
-
"Main Lesson From Pandemic Is...": WHO Chief Scientist To NDTV
Speaking to NDTV, when asked about the validity of vaccines as many got infected with Covid even after taking booster doses, she said the doses prevent severe disease.
-
Monkeypox Has Been A "Wake-Up Call", Says WHO Chief Scientist
The outbreak of Monkeypox has been a "wake-up call", Chief Scientist at the World Health Organisation, Soumya Swaminathan has said.
-
In WHO Chief Scientist's Reply To World Bank Adviser, A Covid Warning
Be prepared for fresh COVID-19 waves, WHO chief scientist Soumya Swaminathan has warned, amid the onset of new variants that are more transmissible, immune evasive and growing concerns about greater hospitalisations.
-
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
